Jennifer Shannon
GlaxoSmithKline (United States)(US)
Publications by Year
Research Areas
Pancreatic and Hepatic Oncology Research, Reproductive Biology and Fertility, Neuroendocrine Tumor Research Advances, Coronary Interventions and Diagnostics, Prenatal Screening and Diagnostics
Most-Cited Works
- → Pancreatic Cancer hENT1 Expression and Survival From Gemcitabine in Patients From the ESPAC-3 Trial(2013)333 cited
- → The Impact of Positive Resection Margins on Survival and Recurrence Following Resection and Adjuvant Chemotherapy for Pancreatic Ductal Adenocarcinoma(2017)249 cited
- → MERKEL CELL CARCINOMA: IMPROVED OUTCOME WITH ADJUVANT RADIOTHERAPY(2005)135 cited
- → Metastatic cutaneous squamous cell carcinoma of the head and neck(2009)128 cited
- → Paclitaxel sensitivity in relation to ABCB1 expression, efflux and single nucleotide polymorphisms in ovarian cancer(2014)35 cited
- → Relationship between cardiovascular risk factors and biomarkers with necrotic core and atheroma size: a serial intravascular ultrasound radiofrequency data analysis(2011)26 cited
- → hENT1 Predicts Benefit from Gemcitabine in Pancreatic Cancer but Only with Low CDA mRNA(2021)12 cited
- → Darapladib effect on circulating high sensitive troponin in patients with acute coronary syndromes(2012)8 cited
- → Foreword(2019)8 cited
- → 6.27 Exploring the Real-World Performance of an Artificial Intelligence-Based Diagnostic Device for ASD: An Aggregate Analysis of Early Canvas Dx Prescription and Output Data(2023)5 cited